"Pharmaceutical Vehicles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)
| Descriptor ID |
D014677
|
| MeSH Number(s) |
D26.650.700 D27.720.744.770 E02.319.300.754
|
| Concept/Terms |
Pharmaceutical Vehicles- Pharmaceutical Vehicles
- Pharmaceutical Vehicle
- Vehicle, Pharmaceutical
- Vehicles, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Vehicles".
Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Vehicles".
This graph shows the total number of publications written about "Pharmaceutical Vehicles" by people in this website by year, and whether "Pharmaceutical Vehicles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmaceutical Vehicles" by people in Profiles.
-
Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function. J Clin Pharmacol. 2011 Aug; 51(8):1205-12.
-
Drug loading of nanoporous TiO2 films. Biomed Mater. 2006 Dec; 1(4):L11-5.
-
Comment on the publication "Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase in lens density" by W. Kai et al. Graefes Arch Clin Exp Ophthalmol. 2007 Jan; 245(1):179-80; author reply 181-2.
-
Hyperosmolar metabolic acidosis and intravenous Lorazepam. N Engl J Med. 2002 Sep 12; 347(11):857-8; author reply 857-8.
-
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol. 1997 Jul; 37(1):85-92.
-
Reconstruction of large diaphyseal defects, without free fibular transfer, in Grade-IIIB tibial fractures. J Bone Joint Surg Am. 1989 Aug; 71(7):994-1004.
-
Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles. Cancer Res. 1986 Dec; 46(12 Pt 1):6269-73.
-
Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng. 1978; 7:435-68.